Elevated dopa decarboxylase activity in living brain of patients with psychosis.
about
The dopamine hypothesis of schizophrenia: version III--the final common pathwaySingle photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjectsTrace amine-associated receptor 1-Family archetype or iconoclast?Increased baseline occupancy of D2 receptors by dopamine in schizophreniaAuditory neuroimaging with fMRI and PET.Comparative sequencing and association studies of aromatic L-amino acid decarboxylase in schizophrenia and bipolar disorder.Abnormal relationship between medial temporal lobe and subcortical dopamine function in people with an ultra high risk for psychosis.Imaging glutamate in schizophrenia: review of findings and implications for drug discovery.Combining fMRI and SNP data to investigate connections between brain function and genetics using parallel ICA.The extended amygdala and the dopamine system: another piece of the dopamine puzzle.Model-based optimization approaches for precision medicine: A case study in presynaptic dopamine overactivity.Dopamine as the wind of the psychotic fire: new evidence from brain imaging studies.Schizophrenia: an integrated sociodevelopmental-cognitive model.A possible role for the striatum in the pathogenesis of the cognitive symptoms of schizophrenia.Dopamine D2 receptor levels in striatum, thalamus, substantia nigra, limbic regions, and cortex in schizophrenic subjects.Striatal presynaptic dopamine in schizophrenia, part II: meta-analysis of [(18)F/(11)C]-DOPA PET studies.Is schizophrenia a dopamine supersensitivity psychotic reaction?Presynaptic regulation of dopamine transmission in schizophrenia.Seasonal effects on human striatal presynaptic dopamine synthesisEstrogenic modulation of brain activity: implications for schizophrenia and Parkinson's disease.Pathway-Specific Dopamine Abnormalities in Schizophrenia.Tardive dyskinesia in the era of typical and atypical antipsychotics. Part 1: pathophysiology and mechanisms of induction.The role of dopamine for the pathophysiology of schizophrenia.Investigational drugs for schizophrenia targeting the dopamine receptor: phase II trials.Dopamine in the history of the schizophrenic brain: recent contributions of brain-imaging studies.Dopamine D2 and D3 binding in people at clinical high risk for schizophrenia, antipsychotic-naive patients and healthy controls while performing a cognitive taskPET radiopharmaceuticals for probing enzymes in the brainDopaminergic function in the psychosis spectrum: an [18F]-DOPA imaging study in healthy individuals with auditory hallucinations.Complexity of dopamine metabolism.Mechanisms of dopaminergic and serotonergic neurotransmission in Tourette syndrome: clues from an in vivo neurochemistry study with PET.Glutamate and dopamine in schizophrenia: an update for the 21st centuryMolecular imaging studies of the striatal dopaminergic system in psychosis and predictions for the prodromal phase of psychosisThe nature of dopamine dysfunction in schizophrenia and what this means for treatment.Proton magnetic resonance spectroscopy of the substantia nigra in schizophreniaMidbrain dopamine function in schizophrenia and depression: a post-mortem and positron emission tomographic imaging studyMolecular imaging as a guide for the treatment of central nervous system disordersImaging frontostriatal function in ultra-high-risk, early, and chronic schizophrenia during executive processing.Schizophrenia: from the brain to peripheral markers. A consensus paper of the WFSBP task force on biological markers.Executive function, neural circuitry, and genetic mechanisms in schizophrenia.Ventral striatum gray matter density reduction in patients with schizophrenia and psychotic emotional dysregulation.
P2860
Q22242827-6E38FC0B-B77B-4279-BA37-859A30789F6CQ22248075-42B6BB71-77E3-4180-A408-8F14144D2055Q24648659-71B5B3C9-FD9A-43D2-AF4E-D93BF0F9954BQ24676113-B84D7260-09F3-46EA-AC30-4980416222C7Q28660586-1A9038F4-A290-4EA3-BDE3-2F3F13CD7892Q30326972-97617826-CAD7-4703-B050-B0AE143080EDQ30450082-BE962985-1C35-43D5-B3EA-D1E18005E7AAQ30685335-4522133C-D2D8-4A97-A1AD-BB473EDC2EACQ31139562-44E78258-D085-47B1-9D80-59B0E3C01C5DQ33338648-E189DD08-9F71-486E-9869-A2EACA88C0FAQ33797632-C0F60AFB-8673-4E2E-9BB8-8C6FFEC917BFQ33833648-765479D0-4D6D-4CFB-99D7-F005A16D1E15Q34023115-900C24DE-89E4-458E-8713-0237486D99DAQ34103482-FA8232EC-B8BE-4328-953C-F12B2E449835Q34183875-0C250F0D-BF66-4AD7-98EA-14F00BAEC7CAQ34250017-9F9FEEE8-8517-46B2-A6F7-1D2CEC47B09AQ34377871-C8A02D24-C4DF-40B0-A002-35593C728498Q34415890-C5C5B99F-A1F0-4924-BFE3-B727B76E1A3BQ34443699-CB66E1D9-EF69-4EB8-8E42-D1B81C8B60E4Q34523361-CE706B32-9905-4F28-B267-374D78F2FA83Q34527656-0E961A27-66BC-485F-8564-644234328998Q34651191-031223BF-16C5-44C8-8AF6-DE812937D8F7Q34658860-C9979802-6C62-4636-B92A-FEC26B32B025Q34703195-8E70E501-42DE-4482-8F32-AFE26BEFEF0CQ35236303-D91C5045-ED3B-45CA-AB6D-5E7BD8C2D61CQ36636329-CED517DD-A1D8-4BCE-B6DB-70DDBE12B9AFQ36769219-63EE0140-5712-44CE-A60E-B87CDBE8040CQ36939999-ACCBB09A-1AB6-4954-B2D2-330EC24F51F3Q36958208-2FFC8D55-5151-40E8-A712-64585AD8A8F8Q36966673-95FDBC09-93E6-4B15-AD3D-71EC76E6467FQ36992322-DE453CFA-82B1-496C-8347-E6050F9EB913Q37022940-24EFEF40-E31E-4B64-B40E-92277D779CC5Q37062793-5C8633C9-FE94-4AC7-8B2C-E2A9589DB4C7Q37141400-99BA1A02-A1F6-4DF2-9B35-6B7DE653D666Q37256211-624D6DAF-D41E-4E76-AB5B-E147EB6887AFQ37262953-530B962F-3B37-4989-B9EE-0A9387383325Q37320771-39829C1C-1E79-4442-A1C5-9686A47DD5C7Q37461052-A295EC5D-4A9F-4415-B160-3B09B2FACC11Q37480047-15A8227D-A4B1-458A-A9A4-9F6020ED0B7FQ37492982-34B9E7A0-0255-4A83-A424-709D2BE4377E
P2860
Elevated dopa decarboxylase activity in living brain of patients with psychosis.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Elevated dopa decarboxylase activity in living brain of patients with psychosis.
@ast
Elevated dopa decarboxylase activity in living brain of patients with psychosis.
@en
type
label
Elevated dopa decarboxylase activity in living brain of patients with psychosis.
@ast
Elevated dopa decarboxylase activity in living brain of patients with psychosis.
@en
prefLabel
Elevated dopa decarboxylase activity in living brain of patients with psychosis.
@ast
Elevated dopa decarboxylase activity in living brain of patients with psychosis.
@en
P2093
P2860
P356
P1476
Elevated dopa decarboxylase activity in living brain of patients with psychosis.
@en
P2093
C Benkelfat
F Andermann
G Chouinard
H Kuwabara
P2860
P304
11651-11654
P356
10.1073/PNAS.91.24.11651
P407
P577
1994-11-01T00:00:00Z